Great news! Fast Track for Clinical Trial Program has been approved by the Department of Industrial Technology of the Ministry of Economic Affairs (MOEA).

After 7 years of hard work and perseverance, our proprietary non-invasive, electroceutical technology for treating and alleviating symptoms associated with type 2 diabetes has been approved by MOEA for R&D subsidies.